Clinical Practice guidelines for the use of erythropoiesis-stimulating agents (ESA: Epoetin alfa, epoetin bêta, darbepoetin) in anaemic patients with cancer: 2007 Update (summary report);Indication des agents stimulant l'érythropoïèse (ASE: Époétine alpha, époétine bêta et darbépoétine) dans la prise en charge de l'anémie en cancérologie (mise à jour), rapport abrégé

Bulletin du Cancer

Volumn 95, Issue 4, 2008, Pages 433-441

  Ray Coquard, Isabelle ^a   Kassab Chahmi, Diana ^b   Casadevall, Nicole ^c   Chastagner, Pascal ^d   Marchal, Christian ^e   Marec Bérard, Perrine ^a   Misset, Jean Louis ^f  

^a CENTRE LÉON BÉRARD   (France)

^b FNCLCC   (France)

^c HÔPITAL SAINT ANTOINE   (France)

^d HÔPITAL D ENFANTS   (France)

^e CENTRE ALEXIS VAUTRIN   (France)

^f SAINT LOUIS HOSPITAL   (France)

Author keywords

Anaemia; Cancer; Epoetin; ESA; Guidelines; Iron

Indexed keywords

ERYTHROPOIETIN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RECOMBINANT ERYTHROPOIETIN; ANTIANEMIC AGENT; DRUG DERIVATIVE; IRON DERIVATIVE;

ALGORITHM; ANEMIA; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL ASSESSMENT; DRUG INDICATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; MEDICAL SPECIALIST; PATIENT CARE; PRACTICE GUIDELINE; STANDARD; TREATMENT INDICATION; ADULT; CHILD; FRANCE; NEOPLASM; REVIEW;

ADULT; ANEMIA; CHILD; EPOETIN ALFA; ERYTHROPOIETIN; ERYTHROPOIETIN, RECOMBINANT; FRANCE; HEMATINICS; HUMANS; IRON COMPOUNDS; NEOPLASMS;

EID: 43249099108     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: None     Document Type: Article

References (45)